FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used to use a compound of formula (Iq) for the preparation of a medicament for the treatment of a retroviral infection and a pharmaceutically acceptable salt thereof, where the retroviral infection is caused by a retrovirus, which is the human leukemia virus HTLV1. Compound is represented by formula (Iq) (Iq), where R independently represents a hydrogen atom, (C1-C3)alkoxy group or (C1-C3)fluoroalkoxy group, R'' represents a hydrogen atom, R' represents a hydrogen atom or a group selected from the group -NR1R2, N-methylpiperazinyl group, (C1-C3)alkoxy and morpholino groups, R1 and R2 independently represent a hydrogen atom or (C1-C3)alkyl group, n equals 1, n' equals 1.
EFFECT: use of this compound can inhibit the splicing of the retrovirus RNA, effectively inhibiting HTLV1.
1 cl, 2 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
MICRORNA-124 AS BIOMARKER | 2014 |
|
RU2687366C2 |
QUINOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING VIRAL INFECTION | 2016 |
|
RU2723016C2 |
NOVEL QUINOLINE DERIVATIVE FOR USE IN TREATING AND PREVENTING VIRAL INFECTIONS | 2016 |
|
RU2723013C2 |
APPLICATION OF ADAPTED RECOMBINASES FOR CURING OF RETROVIRAL INFECTIONS | 2008 |
|
RU2501860C2 |
LENTIVIRAL VECTORS PSEUDOTYPED BY MUTANT BaEV GLYCOPROTEINS | 2012 |
|
RU2618864C2 |
QUINOLINE DERIVATIVES FOR USE IN TREATMENT OR PREVENTION OF CANCER | 2019 |
|
RU2811417C2 |
COMPOUNDS APPLICABLE FOR TREATING AIDS | 2010 |
|
RU2575845C2 |
COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | 2009 |
|
RU2505306C2 |
HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS FOR USE AGAINST CANCER AND VIRAL INFECTIONS | 2015 |
|
RU2766087C2 |
WATER-SOLUBLE STRONG-CHAIN OLIGOESTER, METHOD OF ITS SYNTHESIS AND COMPOSITION BASED ON THEREOF | 1992 |
|
RU2108345C1 |
Authors
Dates
2019-03-14—Published
2014-07-04—Filed